{
    "id": 13134,
    "fullName": "SMARCB1 loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "SMARCB1 loss indicates loss of the SMARCB1 gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 6598,
        "geneSymbol": "SMARCB1",
        "terms": [
            "SMARCB1",
            "BAF47",
            "CSS3",
            "hSNFS",
            "INI1",
            "MRD15",
            "PPP1R144",
            "RDT",
            "RTPS1",
            "Sfh1p",
            "SNF5",
            "SNF5L1",
            "Snr1",
            "SWNTS1"
        ]
    },
    "variant": "loss",
    "createDate": "10/15/2015",
    "updateDate": "09/19/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5772,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tazemetostat (EPZ-6438) inhibited growth of SMARCB1-deficient malignant rhabdoid tumor cell lines in culture, and inhibited H3K27 trimethylation and induced tumor regression in a SMARCB1-deleted human malignant rhabdoid tumor cell line xenograft model (PMID: 23620515).",
            "molecularProfile": {
                "id": 13297,
                "profileName": "SMARCB1 loss"
            },
            "therapy": {
                "id": 2683,
                "therapyName": "Tazemetostat",
                "synonyms": null
            },
            "indication": {
                "id": 3672,
                "name": "rhabdoid cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2724,
                    "pubMedId": 23620515,
                    "title": "Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23620515"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10779,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CFI-400945 inhibited proliferation and decreased survival and migration of SMARCB1-deficient atypical teratoid rhabdoid tumor cells in culture (PMID: 28398638).",
            "molecularProfile": {
                "id": 13297,
                "profileName": "SMARCB1 loss"
            },
            "therapy": {
                "id": 4029,
                "therapyName": "CFI-400945",
                "synonyms": null
            },
            "indication": {
                "id": 2129,
                "name": "atypical teratoid rhabdoid tumor",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8816,
                    "pubMedId": 28398638,
                    "title": "A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28398638"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13297,
            "profileName": "SMARCB1 loss",
            "profileTreatmentApproaches": [
                {
                    "id": 8840,
                    "name": "CDK Inhibitor (Pan)",
                    "profileName": "SMARCB1 loss"
                },
                {
                    "id": 8839,
                    "name": "CDK4/6 Inhibitor",
                    "profileName": "SMARCB1 loss"
                },
                {
                    "id": 8580,
                    "name": "EZH2 inhibitor",
                    "profileName": "SMARCB1 loss"
                },
                {
                    "id": 8578,
                    "name": "Fenretinide",
                    "profileName": "SMARCB1 loss"
                },
                {
                    "id": 8576,
                    "name": "MRX34",
                    "profileName": "SMARCB1 loss"
                }
            ]
        },
        {
            "id": 32249,
            "profileName": "SMARCB1 loss TP53 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}